The trimodality treatment approach in stage III/pN2 non-small cell lung cancer: "usually appropriate" may well be a very inappropriate treatment option

  1. Jeremic, B.
  2. Casas, F.
  3. Dubinsky, P.
  4. Cihoric, N.
  5. Gomez-Caamano, A.
Revista:
American Journal of Clinical Oncology: Cancer Clinical Trials

ISSN: 1537-453X,  0277-3732

Ano de publicación: 2015

Volume: 38

Número: 6

Páxinas: 645

Tipo: Carta

DOI: 10.1097/COC.0000000000000223 GOOGLE SCHOLAR
Fonte de datos: Scopus